FDA approves Ibtrozi for ROS1+ non-small cell lung cancer based on data from over 300 patients in two pivotal trials showing ...

Fartcoin (CRYPTO: FARTCOIN) is turning heads after a 40% rally over the past week, outpacing legacy meme coins like Dogecoin ...

FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis ...

Alpha Liquid Terminal launches ChatAnalyst, an AI-powered research tool for crypto, equities, FX, and private markets.

BofA's Lutz raised Cardinal Health's target to $170, citing specialty growth momentum and a shrinking scale gap as key upside ...

WEC Energy Group's WEC short percent of float has fallen 13.21% since its last report. The company recently reported that it ...

Kazia on Wednesday announced positive preclinical data for its paxalisib drug in triple-negative breast cancer. The company's ...

Oklo Inc (NYSE:OKLO) shares are surging Wednesday after the company was selected as an intended awardee to provide power at ...

Harrow licensed U.S. rights to FDA-approved BYQLOVI for post-surgical eye pain and adds momentum to its branded ophthalmic ...

Outlook: Gitlab sees second-quarter adjusted earnings per share from 16 cents to 17 cents, versus the consensus estimate of ...

With an expense ratio of 0.30%, VGMS is cheaper than the average actively managed bond ETF, living up to Vanguard's ...

The immediate trigger for the stock market moving into zone 1 is the release of Consumer Price Index (CPI) data. CPI came ...